SLRX
Salarius Pharmaceuticals Inc

12,876
Mkt Cap
$4.05M
Volume
20,988.00
52W High
$415.80
52W Low
$6.18
PE Ratio
-0.02
SLRX Fundamentals
Price
$7.62
Prev Close
$7.49
Open
$7.60
50D MA
$8.89
Beta
0.12
Avg. Volume
15,047.30
EPS (Annual)
-$1,043.06
P/B
0.14
Rev/Employee
$0.00
$0.4422
Loading...
Loading...
News
all
press releases
Salarius Pharmaceuticals (NASDAQ:SLRX) CFO Purchases $16,000.00 in Stock
Salarius Pharmaceuticals, Inc. (NASDAQ:SLRX - Get Free Report) CFO Mark Rosenblum purchased 20,000 shares of the company's stock in a transaction on Thursday, November 20th. The stock was purchased...
MarketBeat·4mo ago
News Placeholder
More News
News Placeholder
Penny Stocks To Follow Now - November 12th
Leap Therapeutics, Bitfarms, MSP Recovery, Strive, Salarius Pharmaceuticals, HIVE Digital Technologies, and Beyond Meat are the seven Penny stocks to watch today, according to MarketBeat's stock...
MarketBeat·4mo ago
News Placeholder
Why Did Salarius (SLRX) Shares Soar Over 23% After-Hours?
Salarius Pharmaceuticals shares jumped 23.7% in after-hours trading Tuesday, closing at $1.21 following its public offering announcement. read more...
Benzinga·4mo ago
News Placeholder
Salarius Pharmaceuticals Announces Pricing of $7 Million Underwritten Public Offering
Salarius Pharmaceuticals Announces Pricing of $7 Million Underwritten Public Offering Salarius Pharmaceuticals Announces Pricing of $7 Million Underwritten Public Offering PR Newswire HOUSTON, Nov...
PR Newswire·4mo ago
News Placeholder
Salarius Pharma Stock Jumps After-Hours As Nasdaq Compliance Clears Path For Decoy Merger — Retail Bulls Bet On Breakout
The company’s move removes the last major hurdle to completing its merger with Decoy Therapeutics, a deal aimed at advancing antiviral and cancer drug programs through Decoy’s IMP3ACT platform.
Stocktwits·5mo ago
<
...
1
>

Latest SLRX News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.